2832865-25-3
Chemical Structure
ERD-3111
- CAS No.: 2832865-25-3
- Formula:C45H46F4N8O5
- Molecular Weight:854.89
InChIKey: RASJDLFEGKXLIV-LQFKIQTBSA-N
SMILES: FC(CN1[C@@H](CC2=C([C@H]1C3=C(C=C(C=C3F)N4CCC5(CC4)CCN(C(CN6CC(C=C(C7=C8)C(N(C7=O)C9CCC(NC9=O)=O)=O)=C8C6)=O)CC5)F)C=CC%10=C2C=NN%10)C)F
Biological Activity: ERD-3111 is an orally active PROTAC degrader targeting estrogen receptor α (ERα), with a DC50 of 0.5 nM. ERD-3111 induces ERα degradation in breast cancer cells, and triggers tumor regression or complete inhibition of tumor growth in ER-positive breast cancer xenograft models. ERD-3111 can be used in breast cancer-related research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
ERD-3111 | 98.72% | ERD-3111 is an orally active PROTAC degrader targeting estrogen receptor α (ERα), with a DC50 of 0.5 nM. ERD-3111 induces ERα degradation in breast cancer cells, and triggers tumor regression or complete inhibition of tumor growth in ER-positive breast cancer xenograft models. ERD-3111 can be used in breast cancer-related research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.57
HY-156111ARD-1676 -
Similarity Score 0.53
HY-173066NU227326 -
Similarity Score 0.52
HY-149862ARD-2051 -
Similarity Score 0.51
HY-174131PVTX-321 -
Similarity Score 0.51
HY-180956PROTAC ALK degrader-5 -
Similarity Score 0.50
HY-162282PROTAC METTL3-14 degrader 1 -
Similarity Score 0.50
HY-168162ZLC491 -
Similarity Score 0.50
HY-168555YJ1206 -
Similarity Score 0.49
HY-168274PROTAC TRIB2 degrader-1 -
Explore the MedChemAI to find more analogs
